Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 63 (RNA5SP63) is a member of a large family of 5S ribosomal RNA (rRNA) pseudogenes in the human genome. In contrast to functional 5S rRNA genes, which produce a small, highly conserved RNA essential for ribosome function and protein synthesis[1][3][7], RNA5SP63 is a non-functional "pseudogene" variant that does not encode a functional rRNA molecule and is not incorporated into ribosomes[2]. Like other pseudogenes, RNA5SP63 may have regulatory roles at the RNA level—potentially impacting gene regulation by acting as a source of antisense transcripts, competing endogenous RNAs (ceRNAs), or interacting with RNA-binding proteins—but there is no evidence for any specific function or disease association for this pseudogene[4][6]. It is not considered a therapeutic target, and there are no known drugs, mechanisms of action, biomarkers, or safety concerns directly associated with RNA5SP63.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 63 (RNA5SP63).